World's Best Scientists 2026 revealed!
John R. Mackey

John R. Mackey

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 111 5279 4954 207 197 479 53368

John R. Mackey publications per year

The chart shows the history of publications by John R. Mackey between 1995 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. John R. Mackey published across 31 years, from 1995 to 2025, averaging 19.1 papers a year. Output peaked at 60 publications in 2023. 60 of the 593 publications appeared in the last two years.

No. of publications
20 40 60
Bar chart. Horizontal axis: year, 1995 to 2025. Vertical axis: number of publications, 0 to 60. Peak 60 publications in 2023. 1995: 4 publications 1996: 3 publications 1997: 6 publications 1998: 8 publications 1999: 5 publications 2000: 9 publications 2001: 13 publications 2002: 14 publications 2003: 14 publications 2004: 18 publications 2005: 25 publications 2006: 18 publications 2007: 24 publications 2008: 18 publications 2009: 26 publications 2010: 27 publications 2011: 23 publications 2012: 18 publications 2013: 22 publications 2014: 14 publications 2015: 20 publications 2016: 26 publications 2017: 13 publications 2018: 12 publications 2019: 22 publications 2020: 26 publications 2021: 26 publications 2022: 19 publications 2023: 60 publications 2024: 20 publications 2025: 40 publications
1995 2025

593 publications in total across all disciplines

View publications per year as a table
John R. Mackey: publications per year, 1995 to 2025
Year Publications
1995 4
1996 3
1997 6
1998 8
1999 5
2000 9
2001 13
2002 14
2003 14
2004 18
2005 25
2006 18
2007 24
2008 18
2009 26
2010 27
2011 23
2012 18
2013 22
2014 14
2015 20
2016 26
2017 13
2018 12
2019 22
2020 26
2021 26
2022 19
2023 60
2024 20
2025 40
Total 593
Download as CSV

John R. Mackey publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where John R. Mackey sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 461–480 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 479 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751 479
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

John R. Mackey D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where John R. Mackey sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 110–111 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 111 D-Index — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429 111
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

John R. Mackey is affiliated with the University of Alberta in Canada. Their work spans multiple fields with a primary focus on Medicine and Biochemistry, Genetics and Molecular Biology. Within these broad areas, their research addresses specific subfields including Oncology, Molecular Biology, Biomedical Engineering, Cardiology and Cardiovascular Medicine, and Physiology.

Their recent published papers cover important topics related to cancer treatment and cardiovascular health. Notable publications include:

  • Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer (2022, JAMA)
  • Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100,800 women from 86 randomised trials (2023, The Lancet)
  • Incident Cardiovascular Disease Among Adults With Cancer (2022, JACC CardioOncology)
  • Targeting N-myristoylation for therapy of B-cell lymphomas (2020, Nature Communications)
  • Exercise Intolerance in Anthracycline-Treated Breast Cancer Survivors: The Role of Skeletal Muscle Bioenergetics, Oxygenation, and Composition (2020, The Oncologist)

John R. Mackey frequently collaborates with several researchers including Deepak Dinakaran, Parsin Haji Reza, Luc G. Berthiaume, Benjamin R. Ecclestone, and Edith Pituskin. These collaborations reflect overlapping interests in cancer research, molecular biology, and biomedical sciences.

Their work is often published in prominent scientific venues, particularly:

  • arXiv (Cornell University)
  • Journal of Clinical Oncology
  • Blood
  • Scientific Reports
  • Medicine & Science in Sports & Exercise

John R. Mackey's research topics are diverse but consistently linked to cancer and related physiological and biochemical mechanisms. Key areas of study include:

  • Photoacoustic and Ultrasonic Imaging
  • Cancer survivorship and care
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Ubiquitin and proteasome pathways
  • Thermography and Photoacoustic Techniques
  • Optical Coherence Tomography Applications
  • Protein Degradation and Inhibitors

Throughout their career, John R. Mackey has contributed significant research in oncology and cardiovascular medicine, as well as in imaging technologies and molecular pathways associated with cancer treatment and survivorship.

Best Publications

  • Adjuvant trastuzumab in HER2-positive breast cancer.

    Dennis Slamon;Wolfgang Eiermann;Nicholas Robert;Tadeusz Pienkowski

  • The clonal and mutational evolution spectrum of primary triple-negative breast cancers

    Sohrab P. Shah;Andrew Roth;Rodrigo Goya;Arusha Oloumi

  • Effects of Aerobic and Resistance Exercise in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Multicenter Randomized Controlled Trial

    Kerry S. Courneya;Roanne J. Segal;John R. Mackey;Karen Gelmon

  • Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis

    Margaret L. McNeely;Kristin L. Campbell;Brian H. Rowe;Terry P. Klassen

  • Adjuvant docetaxel for node-positive breast cancer.

    Miguel Martin;Tadeusz Pienkowski;John R Mackey;Marek Pawlicki

  • Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial.

    Lee S. Rosen;David Gordon;Mary Kaminski;Anthony Howell

  • Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial.

    Lee S Rosen;David Gordon;Mary Kaminski;Anthony Howell

  • Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment.

    Carla M.M. Prado;Vickie E. Baracos;Linda J. McCargar;Tony Reiman

  • Trastuzumab plus anastrozole versus anastrozole alone for the treatment of postmenopausal women with human epidermal growth factor receptor 2-positive, hormone receptor-positive metastatic breast cancer: results from the randomized phase III TAnDEM study.

    Bella Kaufman;John R Mackey;Michael R Clemens;Poonamalle P Bapsy

  • Gastric adenocarcinoma: review and considerations for future directions.

    Bryan J. Dicken;David L. Bigam;Carol Cass;John R. Mackey

  • Randomized Controlled Trial of Exercise Training in Postmenopausal Breast Cancer Survivors: Cardiopulmonary and Quality of Life Outcomes

    Kerry S. Courneya;John R. Mackey;Gordon J. Bell;Lee W. Jones

  • Phase III Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC→T) with Doxorubicin and Cyclophosphamide Followed by Docetaxel and Trastuzumab (AC→TH) with Docetaxel, Carboplatin and Trastuzumab (TCH) in Her2neu Positive Early Breast Cancer Patients: BCIRG 006 Study.

    D. Slamon;W. Eiermann;N. Robert;T. Pienkowski

  • Metabolic Modulation of Glioblastoma with Dichloroacetate

    E. D. Michelakis;G. Sutendra;P. Dromparis;L. Webster

  • Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer

    E D Michelakis;L Webster;J R Mackey

  • Nucleoside analogues and nucleobases in cancer treatment.

    Carlos M Galmarini;John R Mackey;Charles Dumontet

  • Functional Nucleoside Transporters Are Required for Gemcitabine Influx and Manifestation of Toxicity in Cancer Cell Lines

    John R. Mackey;Rajam S. Mani;Milada Selner;Delores Mowles

  • Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial

    Judith Hugh;John Hanson;Maggie Chon U. Cheang;Torsten O. Nielsen

  • Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trial

    David Cameron;Julia Brown;Rebecca Dent;Christian Jackisch

  • Early Breast Cancer Therapy and Cardiovascular Injury

    Lee W. Jones;Mark J. Haykowsky;Jonas J. Swartz;Pamela S. Douglas

  • Randomized C ontrolled T rial o f E xercise T raining i n Postmenopausal B reast C ancer S urvivors: C ardiopulmonary and Q uality o f L ife O utcomes

    Kerry S. Courneya;John R. Mackey;Gordon J. Bell;Lee W. Jones

Frequent Co-Authors

Carol E. Cass
Carol E. Cass University of Alberta
Kerry S. Courneya
Kerry S. Courneya University of Alberta
Raymond Lai
Raymond Lai University of Alberta
Karen A. Gelmon
Karen A. Gelmon University of British Columbia
Christine M. Friedenreich
Christine M. Friedenreich Alberta Health Services
Lee W. Jones
Lee W. Jones Memorial Sloan Kettering Cancer Center
James D. Young
James D. Young University of Alberta
Mark J. Haykowsky
Mark J. Haykowsky University of Alberta
Marc Buyse
Marc Buyse Hasselt University
John Crown
John Crown Dublin City University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine opens up a variety of online degree options, each with unique advantages and considerations. For those interested in advanced nursing roles, programs such as the cheapest online fnp programs provide a flexible and cost-effective way to become a family nurse practitioner and meet the growing demand for healthcare professionals.

Affordability is a major concern for many students. It's important to consider how much does online nursing school cost as tuition and fees can vary widely between institutions. Carefully comparing program costs and financial aid opportunities ensures that you choose a path that fits your budget.

For those aiming for leadership, research, or advanced clinical practice, doctoral options like the cheapest dnp programs online can be an efficient way to reach your goals without significant financial burden.

Many registered nurses choose to advance their credentials through bridge programs. Completing your bachelor’s degree via an rn to bsn online program strengthens your skill set and expands career opportunities in the medical field.

Best Scientists Citing John R. Mackey

Trending Scientists

Recently Published Articles